Malaria Vaccine Market Research Report, Share, and Forecast to 2025Posted by rekha on October 9th, 2019 The global Malaria Vaccine market accounted for US$ XX Mn in 2018 and burgeoning over the forthcoming years. Increasing government support towards contribution to malaria vaccine, rising incidences of malaria among people and increasing attention towards aftermaths of the disease are some the key factors fostering the market growth. However, factors such as very weak supply chain and distribution networks in developing countries and severe regulatory policies are inhibiting the market growth. In addition, new technological advancements and huge R & D investments in this market provides huge growth opportunity for the market. Global Malaria Vaccine market segmented on the basis of type of vaccine, target, end user and region. For request sample: https://www.precisionbusinessinsights.com/request-sample?product_id=19246 DNA Vaccines dominate the Global Malaria Vaccine Market Based on type of vaccine, global Malaria Vaccine market is protein vaccine, DNA vaccines and others. DNA Vaccines held considerable market growth during estimated period. Vaccination is the attempt to mimic certain aspects of an infection for the purpose of causing an immune response that will protect the individual from that infection. Malaria, a disease responsible for immense human suffering, is caused by infection with Plasmodium spp. DNA vaccination provides a stable and long-lived source of protein vaccine capable of inducing both antibody- and cell-mediated immune responses to a wide variety of antigens. Injected DNA enters the cells of the host and makes the protein, which triggers the immune response. The flexibility of DNA vaccine technology permits the combination of multiple antigens from both the preerythrocytic and erythrocytic stages of malaria parasite. Middle East & Africa Leads the Global Malaria Vaccine market
PBI’s global Malaria Vaccine market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis.Middle East & Africa accounted for larger revenue share in global Malaria Vaccine market with considerable CAGR. The growth in this region is due to most of the people in this region affected with malaria disease drives the malaria vaccine market. Further, North America and Europe regions held considerable market share during estimated period. Strategic New Product Launches are the Key Strategies Adopted by Market Players
Global Malaria Vaccine market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For Instance, in 2019, world's first malaria vaccine was launched in Malawi to protect children from the deadly diseases. The launch of the first and only malaria vaccine, known as RTS, makes Malawi the first of three countries in Africa vaccine available to children up to 2 years of age. Key player’s profiles in the report areGlaxoSmithKline Plc (U.K.), Sanaria Inc. (U.S.), Mymetics Corporation (Switzerland), Novovax Inc. (U.S.)., Sumaya Biotech, Nobelpharma Co., Ltd. and GenVec, Inc. Precision Business Insights (PBI) in its report titled “Global Malaria Vaccine Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Moreover, the report also includes the total revenue and volume for the market. Detailed Segmentation
By Type of Vaccine o Protein Vaccine o DNA Vaccines o Others By Target o Pre-Erythrocytic Stage o Erythrocytic Stage o Combined Vaccines By End User o Hospitals o Vaccination Centres o Others
By Geography o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)
For more information: https://www.precisionbusinessinsights.com/market-reports/malaria-vaccine-market/ Like it? Share it! More by this author |